Dallen Medical announced the first human use of its Compressyn Staple, a rigid compression fixation technology that delivers continuous compression for small bone fixation.
The staple was cleared by the U.S. Food and Drug Administration in 2013, and it is designed for a broad range of foot, ankle and hand fixation. For the first time, it was used to perform the calcaneal cuboid fusion of a triple arthrodesis for treatment of an arthritic foot.
"Our next generation staple system improves upon the drawbacks of nitinol and other stainless steel staples to deliver more consistent, dynamic compression designed to improve patient outcomes," said Dallen Medical CEO David Mills.
Dallen Medical is an early-stage orthopedic company whose patented technology aims at providing superior fixation and compression.
More articles on devices:
K2M stock hits crucial point — 5 things to know
Providence Medical Technology gets 3 spine-related patents
Amedica appoints Anan Natarajan vice president of business development